SVP And Chief Scientific Officer Of Ideaya Biosciences Trades $394.04 Thousand In Company Stock
Michael P Dillon, SVP And Chief Scientific Officer at Ideaya Biosciences (NASDAQ:IDYA), made a large buy and sell of company shares on September 8, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission reports that on September 8, Michael P Dillon bought 11,500 Ideaya Biosciences shares at prices ranging from $4.31 to $11.08 per share, for a total of $78,764. They then sold their shares on succeeding transactions in the open market at prices ranging from $27.41 to $27.67 to raise a total of $315,278 from the sale.
Following the transaction, Dillon still owns 78,789 shares of the company, worth $2,053,241.
Ideaya Biosciences shares are trading down 1.55% at $26.06 at the time of this writing on Friday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
The Importance of Insider Transactions
Insider transactions shouldn’t be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.
In legal terms, an “insider” refers to any shareholder who owns at least 10% of a company. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down.
Important Transaction Codes
Investors prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates the insider may have been forced to sell shares in order to receive compensation that had been promised upon being hired by the company.
Check Out The Full List Of Ideaya Biosciences’s Insider Trades.
See more from Benzinga
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
